- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
BrightPath Biotherapeutics Co Ltd (4594)
BrightPath Biotherapeutics Co Ltd stock price live, this page displays TYO 4594 stock exchange data. View the 4594 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the BrightPath Biotherapeutics Co Ltd real time stock price chart below.
What Is the BrightPath Biotherapeutics Co Ltd Stock Price Today?
The BrightPath Biotherapeutics Co Ltd stock price today is 71.0.
What Is the Stock Symbol for BrightPath Biotherapeutics Co Ltd?
The stock symbol for BrightPath Biotherapeutics Co Ltd is ""4594.""
What Stock Exchange Does BrightPath Biotherapeutics Co Ltd Trade On?
BrightPath Biotherapeutics Co Ltd is listed and trades on the Tokyo stock exchange.
Is BrightPath Biotherapeutics Co Ltd a Good Stock to Buy?
Determining whether BrightPath Biotherapeutics Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4594 quote. (ISIN: JP3274140007)
What Is the BrightPath Biotherapeutics Co Ltd Stock Price Today?
The BrightPath Biotherapeutics Co Ltd stock price today is 71.0.
What Is the Stock Symbol for BrightPath Biotherapeutics Co Ltd?
The stock symbol for BrightPath Biotherapeutics Co Ltd is ""4594.""
What Stock Exchange Does BrightPath Biotherapeutics Co Ltd Trade On?
BrightPath Biotherapeutics Co Ltd is listed and trades on the Tokyo stock exchange.
Is BrightPath Biotherapeutics Co Ltd a Good Stock to Buy?
Determining whether BrightPath Biotherapeutics Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4594 quote. (ISIN: JP3274140007)
Tokyo
Currency in JPY
71.0
+2.0(+2.90%)
Closed·
Fair Value
An estimate of a BrightPath Biotherapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
68.0
71.0
52 wk Range
32.0
96.0
4594 Scorecard
Full Analysis
Quickly burning through cash
4594 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a BrightPath Biotherapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
68.071.0
52 wk Range
32.096.0
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4594 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a BrightPath Biotherapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Liquid assets exceed short term obligations
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
BrightPath Biotherapeutics Co Ltd Company Profile
BrightPath Biotherapeutics Co., Ltd. engages in the development of cancer immunotherapy drugs in Japan. It is developing GRN-1201, a cancer peptide vaccine candidate that is in Phase II clinical trials for the treatment of non-small cell lung cancer, as well as in Phase I clinical trials to treat melanoma. The company is also developing BP2201, a product candidate in Phase I clinical trials to target cancer antigens in various types of cancer; and BP2301, a product candidate in Phase I clinical trials for the treatment of solid tumors sarcoma and gynecological cancers. In addition, its product candidates in preclinical trials include BP1202 that targets CD39; BP1210, which suppresses T cell cytotoxicity; BP1212 to inhibit TIM-3 and CD39; BP1209 to target tumor-specific neoantigens; and BP1200 to target CD73. The company was formerly known as GreenPeptide Co., Ltd. and changed its name to BrightPath Biotherapeutics Co., Ltd. in July 2017. BrightPath Biotherapeutics Co., Ltd. was incorporated in 2003 and is headquartered in Tokyo, Japan.
Compare 4594 to Peers and Sector
Metrics to compare | 4594 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4594PeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.6x | −7.0x | −0.5x | |
PEG Ratio | −0.25 | 0.04 | 0.00 | |
Price/Book | - | 4.8x | 2.6x | |
Price / LTM Sales | 5,670.7x | 47.1x | 3.3x | |
Upside (Analyst Target) | - | 71.2% | 43.3% | |
Fair Value Upside | Unlock | 13.6% | 6.9% | Unlock |
Earnings
Latest Release
Aug 08, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does BrightPath Biotherapeutics Trade On?
BrightPath Biotherapeutics is listed and trades on the Tokyo Stock Exchange stock exchange.
What Is the Stock Symbol for BrightPath Biotherapeutics?
The stock symbol for BrightPath Biotherapeutics is "4594."
What Is the BrightPath Biotherapeutics Market Cap?
As of today, BrightPath Biotherapeutics market cap is 6.42B.
What Is BrightPath Biotherapeutics's Earnings Per Share (TTM)?
The BrightPath Biotherapeutics EPS (TTM) is -14.12.
When Is the Next BrightPath Biotherapeutics Earnings Date?
BrightPath Biotherapeutics will release its next earnings report on 06 Nov 2025.
From a Technical Analysis Perspective, Is 4594 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has BrightPath Biotherapeutics Stock Split?
BrightPath Biotherapeutics has split 0 times.
How Many Employees Does BrightPath Biotherapeutics Have?
BrightPath Biotherapeutics has 42 employees.
What is the current trading status of BrightPath Biotherapeutics (4594)?
As of 11 Aug 2025, BrightPath Biotherapeutics (4594) is trading at a price of 71.00, with a previous close of 71.00. The stock has fluctuated within a day range of 68.00 to 71.00, while its 52-week range spans from 32.00 to 96.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.